Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 11, 2001, Pages 1777-1785

  Ikeda, S ^a   Tamamuro, T ^a   Hamashima, C ^b   Asaka, M ^c  

^a KEIO UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE;

ARTICLE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ERADICATION THERAPY; GASTRODUODENAL ULCER; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; JAPAN; MODEL; PRIORITY JOURNAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HUMANS; MARKOV CHAINS; OMEPRAZOLE; PENICILLINS; STOMACH ULCER; TREATMENT OUTCOME;

EID: 0034782353     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01106.x     Document Type: Article

References (53)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
2. Helicobacter pylori in peptic ulcer disease
3. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease
4. Cost-effectiveness analysis of different strategies for treating duodenal ulcer. Helicobacter pylori eradication versus antisecretory treatment
5. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies
6. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population
7. Current topics in the treatment of peptic ulcer. Symposium on current therapy in digestive disease
8. Markov models in medical decision making: A practical guide
9. Guidelines in the management of Helicobacter pylori infection in Japan
10. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients
11. Peptic ulceration and its correlation with symptoms
12. The comparison between clinical efficacies of lansoprazole (AG-1749) and famotidine in gastric ulcer patients: Multicenter, double blind trial
13. The comparison between clinical efficacies of lansoprazole (AG-1749) and famotidine in duodenal ulcer patients: Multicenter, double blind trial
14. The role of Helicobacter pylori (Hp) eradication in gastric ulcer healing and relapses
15. Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate
16. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease
17. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer, a randomized, controlled study
18. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori
19. Randomized double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection
20. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients
21. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: A two-year, double-blind, placebo controlled study
22. Two year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin
23. Clinical course of duodenal ulcer disease one year after omeprazole plus amoxycillin or triple therapy plus ranitidine for cure of Helicobacter pylori infection
24. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
25. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone
26. Cure of duodenal ulcer associated with eradication of Helicobacter pylori
27. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind contolled study
28. Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry
29. Famotidine: Proven once-a-day treatment for gastric ulcer
30. Famotidine versus cimetidine in the treatment of benign gastric ulcers: A multicenter, double-blind study
31. A comparison study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers
32. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: Ulcer healing and symptom relief in benign gastric ulcer
33. Nocturnal therapy with famotidine for 1 year is effective in preventing relapse of gastric ulcer
34. A trial of lansoprazole in refractory gastric ulcer
35. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial
36. Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease
37. A multicenter, randomized, double-blind study comparing famotidine with cimetidine in the treatment of active duodenal ulcer disease
38. Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer
39. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer
40. A clinical study on the recurrence of peptic ulcer after the initial treatment with lansoprazole (LPZ) - Comparison with treatment using famotidine (FAM)
41. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse
42. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study
43. Famotidine versus plazebo in der rezidivprophylaxe der ulcus-duodenierkrankung. Eine multizenterstudie in Deutschland, Osterreich und Italien
44. The study of famotidine once at bed-time for the treatment of gastric ulcer - A double blind comparison with famotidine twice daily
45. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial
46. Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an example
47. Pharmacoeconomic analysis of peptic ulcer drugs
48. Economic evaluation of Helicobacter pylori eradication for the treatment of duodenal ulcer disease in Japan: A decision analysis to assess eradication strategy in comparison with a conventional strategy
49. Can the eradication therapy for Helicobacter pylori save medical cost?